33 lines
1.3 KiB
R
33 lines
1.3 KiB
R
% Generated by roxygen2: do not edit by hand
|
||
% Please edit documentation in R/wihs.R
|
||
\docType{data}
|
||
\name{wihs}
|
||
\alias{wihs}
|
||
\title{Women's Interagency HIV Study}
|
||
\format{A data frame with 1164 rows and 6 variables: \describe{
|
||
\item{time}{time to the event} \item{status}{denotes which event occurred.
|
||
0 denotes censoring, 1 denotes HIV treatment began, and 2 denotes AIDS
|
||
developed or the patient died} \item{ageatfda}{patient age at time first
|
||
treatment approved} \item{idu}{binary specifying if the patient has a
|
||
history of drug injections (1 if true)} \item{black}{binary specifying if
|
||
the patient is black (1 if true)} \item{cd4nadir}{blood count of CD4 cells}
|
||
}}
|
||
\source{
|
||
The data was obtained from the randomForestSRC R package.
|
||
}
|
||
\usage{
|
||
wihs
|
||
}
|
||
\description{
|
||
A dataset containing competing risks information for women with HIV;
|
||
recording the time to treatment, or the time to developing AIDS or death. The
|
||
time may also be censored.
|
||
}
|
||
\references{
|
||
Bacon MC, von Wyl V, Alden C, Sharp G, Robison E, Hessol N, Gange
|
||
S, Barranday Y, Holman S, Weber K, Young MA (2005). “The Women’s
|
||
Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to
|
||
the Bench.” Clinical and Vaccine Immunology, 12(9), 1013–1019.
|
||
doi:10.1128/CDLI.12.9.1013-1019.2005.
|
||
}
|
||
\keyword{datasets}
|